Here, we have characterized the humoral immune response in CRC patients against the different p53 and p63 proteoforms, as the p53 protein family has been widely associated with cancer and reported to regulate several biological processes, such as cell differentiation, proliferation, and apoptosis. Here, TP53 is linked to colorectal carcinoma.